Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Anvisa Includes Ozivy, Brazilian Synthetic Semaglutide Pen, in the Generic Reference List

Summary by Globo
Ozivy Disclosure The National Agency for Health Surveillance (Anvisa) included Ozivy, a medicine based on semaglutide, in the List of Reference Medicines (MRL). The update was published in the Official Journal of the Union on Friday (10). Inclusion does not represent a new approval of the medicine. It means that the product is used as a reference of quality, safety and efficacy so that other laboratories can develop generic or similar versions i…

2 Articles

GloboGlobo
Lean Right

Anvisa Includes Ozivy, Brazilian Semaglutide, in the List of Reference Medicines

Ozivy Disclosure The National Agency for Health Surveillance (Anvisa) included Ozivy, a medicine based on semaglutide, in the List of Reference Medicines (MRL). The update was published in the Official Journal of the Union on Friday (10). Inclusion does not represent a new approval of the medicine. It means that the product is used as a reference of quality, safety and efficacy so that other laboratories can develop generic or similar versions i…

·Brazil
Read Full Article
tnh1.com.brtnh1.com.br

Anvisa Includes Ozivy, Brazilian Synthetic Semaglutide Pen, in the Generic Reference List

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Globo broke the news in Brazil on Friday, July 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

Brazil icon

Brazil

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal